| 241.89 -7.21 (-2.89%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 314.54  |
1-year : | 337.85 |
| Resists | First : | 269.3 |
Second : | 289.26 |
| Pivot price | 248.51 |
|||
| Supports | First : | 237.02 |
Second : | 197.2 |
| MAs | MA(5) : | 247.62  |
MA(20) : | 252.44 |
| MA(100) : | 296.83 |
MA(250) : | 295.36 |
|
| MACD | MACD : | -8.9 |
Signal : | -10 |
| %K %D | K(14,3) : | 30 |
D(3) : | 29.7 |
| RSI | RSI(14): 36.8 |
|||
| 52-week | High : | 354.88 | Low : | 230.05 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PODD ] has closed above bottom band by 20.3%. Bollinger Bands are 30.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 246.27 - 247.61 | 247.61 - 248.73 |
| Low: | 233.79 - 235.45 | 235.45 - 236.83 |
| Close: | 239.35 - 241.92 | 241.92 - 244.06 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Sat, 21 Feb 2026
Insulet Corp (PODD) Shares Down 3.83% on Feb 20 - GuruFocus
Thu, 19 Feb 2026
Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations (NASDAQ:PODD) - Seeking Alpha
Thu, 19 Feb 2026
Cumberland Partners Ltd Purchases Shares of 9,000 Insulet Corporation $PODD - MarketBeat
Thu, 19 Feb 2026
Insulet Corporation (NASDAQ:PODD) Q4 2025 Earnings Call Transcript - Insider Monkey
Thu, 19 Feb 2026
PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise - Nasdaq
Thu, 19 Feb 2026
Vanguard Group Inc. Has $2.72 Billion Holdings in Insulet Corporation $PODD - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 70 (M) |
| Shares Float | 70 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 101.8 (%) |
| Shares Short | 1,980 (K) |
| Shares Short P.Month | 2,080 (K) |
| EPS | 3.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.68 |
| Profit Margin | 9.7 % |
| Operating Margin | 16.6 % |
| Return on Assets (ttm) | 8.7 % |
| Return on Equity (ttm) | 19.6 % |
| Qtrly Rev. Growth | 29.8 % |
| Gross Profit (p.s.) | 25.44 |
| Sales Per Share | 35.82 |
| EBITDA (p.s.) | 7.26 |
| Qtrly Earnings Growth | 14.8 % |
| Operating Cash Flow | 534 (M) |
| Levered Free Cash Flow | 215 (M) |
| PE Ratio | 70.52 |
| PEG Ratio | 0 |
| Price to Book value | 12.29 |
| Price to Sales | 6.75 |
| Price to Cash Flow | 31.89 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|